|Description||CS 722 is a neuromuscular blocking agent and centrally acting muscle relaxant. It exerts its muscle relaxant action by affecting both the supraspinal structure and the spinal cord. In Oct 2000, Phase II for Hypertonia in Japan was discontinued.|
|Synonyms||CS 722; CS-722; CS722. 4-Chloro-2-(2-hydroxy-3-morpholinopropyl)-5-phenyl-4-isoxazolin-3-one|
|Solubility||Soluble in DMSO|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Originator Sankyo|
7DW8-5, a novel glycolipid, an analog of α-galactosylceramide (α-GalCer), is an immunostimulate iNKT agonist and a vaccine adjuvant that can harness and amplify...
S 07662 is an inverse agonist of the constitutive androstane receptor (CAR). S 07662 inhibits CAR activity via recruitment of nuclear receptor co-repressor (NCo...
GYKI-13324 is bifunctional nitrosoureido derivative and alkylating agent. It can produce long-term or total regression of adenomatous, but only marginal growth ...
FCE 26644, also known as PNU-145156E, has been found to be a angiogenesis inhibitor that could have probable effect against solid tumours. It has already been d...
NKH477 is a water-soluble analog of forskolin, which is an adenylyl cyclase activator, but it is sparingly soluble in aqueous solutions. It has both inotropic a...
triptophenolide is isolated from ethyl acetate extracts of the roots of Tripterygium wilfordii Hook. f. In vitro, it can remarkably inhibit the delayed type hyp...
As A very potent uncoupler of oxidative phosphorylation in mitochondria, FCCP transports protons across cell membranes which disrupts ATP synthesis,
Neridronic acid is a Bone resorption factor inhibitor and it can be used to treat Osteogenesis imperfecta and Paget's disease of bone.